RWA Wealth Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.96M Sell
21,405
-3,202
-13% -$280K 0.02% 266
2026
Q1
$2.1M Sell
24,607
-149,196
-86% -$13.3M 0.02% 253
2025
Q4
$13.7M Sell
173,803
-8,455
-5% -$663K 0.15% 89
2025
Q3
$14.6M Sell
182,258
-825
-0.5% -$70.4K 0.17% 83
2025
Q2
$16.6M Sell
183,083
-63,763
-26% -$5.82M 0.21% 75
2025
Q1
$23.1M Buy
246,846
+62,523
+34% +$5.6M 0.29% 56
2024
Q4
$16.8M Sell
184,323
-2,664
-1% -$254K 0.21% 73
2024
Q3
$19.4M Buy
186,987
+1,461
+0.8% +$149K 0.24% 62
2024
Q2
$18M Sell
185,526
-2,836
-2% -$262K 0.24% 68
2024
Q1
$17M Sell
188,362
-5,187
-3% -$439K 0.23% 72
2023
Q4
$15.4M Buy
193,549
+102,361
+112% +$7.7M 0.22% 76
2023
Q3
$6.48M Buy
91,188
+3,839
+4% +$287K 0.14% 74
2023
Q2
$6.73M Buy
87,349
+568
+0.7% +$44K 0.15% 67
2023
Q1
$6.52M Buy
86,781
+3,239
+4% +$241K 0.16% 61
2022
Q4
$6.44M Buy
83,542
+4,906
+6% +$368K 0.16% 64
2022
Q3
$5.52M Buy
78,636
+2,058
+3% +$161K 0.39% 60
2022
Q2
$6.14M Buy
76,578
+73,211
+2,174% +$5.72M 0.41% 54
2022
Q1
$255K Buy
+3,367
New +$267K 0.02% 223
2018
Q3
Sell
-1,490
Closed -$97K 315
2018
Q2
$97K Buy
1,490
+850
+133% +$55.6K 0.01% 327
2018
Q1
$46K Sell
640
-4,000
-86% -$288K 0.01% 350
2017
Q4
$350K Sell
4,640
-33
-0.7% -$2.41K 0.04% 183
2017
Q3
$340K Buy
4,673
+33
+0.7% +$2.38K 0.04% 182
2017
Q2
$344K Buy
4,640
+640
+16% +$47.5K 0.04% 149
2017
Q1
$293K Buy
+4,000
New +$280K 0.04% 157

Other funds holding CL

RWA Wealth Partners's CL Position: Q2 2026 in Review

RWA Wealth Partners reduced its Colgate-Palmolive (CL) stake by 13% in Q2 2026, selling an estimated $280K and leaving 21,405 shares worth $1.96M. The position accounts for 0.02% of the portfolio, ranked #266.

RWA Wealth Partners first reported a position in CL in Q1 2017 and has held it in 24 quarters since. The position peaked at $23.1M in Q1 2025. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • RWA Wealth Partners held 21,405 shares of Colgate-Palmolive worth $1.96M as of Q2 2026.
  • RWA Wealth Partners sold 3,202 Colgate-Palmolive shares in Q2 2026, an estimated $280K.
  • Colgate-Palmolive made up 0.02% of RWA Wealth Partners's portfolio in Q2 2026, its #266 holding.
  • RWA Wealth Partners first reported a position in Colgate-Palmolive in Q1 2017 and has held it in 24 quarters since.
  • RWA Wealth Partners's Colgate-Palmolive position peaked at $23.1M in Q1 2025.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on RWA Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.